The Regional Translational Research Centers (RTRCs) Initiative supports the establishment of collaborative, multi-institution centers to increase interaction between basic and clinical scientists. The goal of this interaction: to accelerate translational development of new drugs, biomarkers, and treatment strategies from the laboratory bench into clinical testing. RTRCs also will provide essential core infrastructure and support, including specialized cores that provide expertise in biostatistics, clinical pharmacology, pharmacogenetics, and genetics. These specialized centers—core RTRCs, or C-RTRCs—may offer this support on a regional or a national level. A third model—expanded RTRCs (E-RTRCs)—combines the RTRC and C-RTRC models. RTRC Planning GrantsOn October 1, 2004, the RTRC Implementation Group prepared and released a planning grant RFA, based on feedback from hundreds of translational research stakeholders (see Planning Meeting). By the January 19, 2005 deadline, NIH received 55 planning grant applications; awards will be made in summer 2005. Regardless of selection for an award, all interested parties are encouraged to submit new or revised applications to future planning grant RFAs. The Implementation Group envisions at least one more round of planning grant RFAs. Please check this Web site frequently for release updates. Regional Translational Research Center Planning Grant (RM RFA-05-008; closed 1-19-05) RTRC GrantsThe RTRC Implementation Group is drafting an RFA that will fund successful applications to develop RTRCs, C-RTRCs, and E-RTRCs. The RFA is targeted for release in October 2005. Past RTRC Events
Comments or queries on the RTRC Initiative and its activities? Please write to nihrtrccomments@mail.nih.gov. PDF documents require the free Adobe Reader. Videos require the free RealPlayer software. |
This page last reviewed: March 14, 2008